AMIX
Autonomix Medical, Inc.Company with tickers: AMIX
CIK
1617867
CUSIP
05330T205
Shares Outstanding
11,409,344
13F Activity (30d)
13 filings
13 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $0 | USD | 2026-03-31 | 10-K | 2026-05-27 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $17,034,000 | USD | 2026-03-31 | 10-K | 2026-05-27 |
| Research & Development | $7,144,000 | USD | 2026-03-31 | 10-K | 2026-05-27 |
| Operating Income | $-17,034,000 | USD | 2026-03-31 | 10-K | 2026-05-27 |
| Net Income | $-16,715,000 | USD | 2026-03-31 | 10-K | 2026-05-27 |
| EPS (Basic) | $-2.32 | USD/shares | 2026-03-31 | 10-K | 2026-05-27 |
| EPS (Diluted) | — |